[{"id":"c5cceb7e-939b-4041-ae50-8a10c0ca146f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05924906","created_at":"2023-06-29T14:09:08.904Z","updated_at":"2024-07-02T16:35:44.156Z","phase":"Phase 1a/1b","brief_title":"A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors","source_id_and_acronym":"NCT05924906","lead_sponsor":"Suzhou Neologics Bioscience Co., Ltd.","biomarkers":" HAVCR2","pipe":"","alterations":" ","tags":["HAVCR2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NB002"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 10/01/2023","start_date":" 10/01/2023","primary_txt":" Primary completion: 04/01/2026","primary_completion_date":" 04/01/2026","study_txt":" Completion: 07/01/2026","study_completion_date":" 07/01/2026","last_update_posted":"2023-07-03"}]